Literature DB >> 29986996

SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium.

Ansu O Perekatt1,2, Pooja P Shah1, Shannon Cheung1, Nidhi Jariwala2,3, Alex Wu1, Vishal Gandhi1, Namit Kumar1, Qiang Feng4, Neeket Patel1, Lei Chen1, Shilpy Joshi2, Anbo Zhou1, M Mark Taketo5, Jinchuan Xing1, Eileen White2, Nan Gao2,4, Michael L Gatza1,2,3, Michael P Verzi6,2.   

Abstract

The cell of origin of colon cancer is typically thought to be the resident somatic stem cells, which are immortal and escape the continual cellular turnover characteristic of the intestinal epithelium. However, recent studies have identified certain conditions in which differentiated cells can acquire stem-like properties and give rise to tumors. Defining the origins of tumors will inform cancer prevention efforts as well as cancer therapies, as cancers with distinct origins often respond differently to treatments. We report here a new condition in which tumors arise from the differentiated intestinal epithelium. Inactivation of the differentiation-promoting transcription factor SMAD4 in the intestinal epithelium was surprisingly well tolerated in the short term. However, after several months, adenomas developed with characteristics of activated WNT signaling. Simultaneous loss of SMAD4 and activation of the WNT pathway led to dedifferentiation and rapid adenoma formation in differentiated tissue. Transcriptional profiling revealed acquisition of stem cell characteristics, and colabeling indicated that cells expressing differentiated enterocyte markers entered the cell cycle and reexpressed stem cell genes upon simultaneous loss of SMAD4 and activation of the WNT pathway. These results indicate that SMAD4 functions to maintain differentiated enterocytes in the presence of oncogenic WNT signaling, thus preventing dedifferentiation and tumor formation in the differentiated intestinal epithelium.Significance: This work identifies a mechanism through which differentiated cells prevent tumor formation by suppressing oncogenic plasticity. Cancer Res; 78(17); 4878-90. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29986996      PMCID: PMC6125228          DOI: 10.1158/0008-5472.CAN-18-0043

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.

Authors:  Yiwen Jiang; Voichita Dana Marinescu; Yuan Xie; Malin Jarvius; Naga Prathyusha Maturi; Caroline Haglund; Sara Olofsson; Nanna Lindberg; Tommie Olofsson; Caroline Leijonmarck; Göran Hesselager; Irina Alafuzoff; Mårten Fryknäs; Rolf Larsson; Sven Nelander; Lene Uhrbom
Journal:  Cell Rep       Date:  2017-05-02       Impact factor: 9.423

2.  Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.

Authors:  Tanner J Freeman; J Joshua Smith; Xi Chen; M Kay Washington; Joseph T Roland; Anna L Means; Steven A Eschrich; Timothy J Yeatman; Natasha G Deane; R Daniel Beauchamp
Journal:  Gastroenterology       Date:  2011-11-22       Impact factor: 22.682

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Generation of Smad4/Dpc4 conditional knockout mice.

Authors:  Xiao Yang; Cuiling Li; Pedro-Luis Herrera; Chu-Xia Deng
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

5.  Dll1+ secretory progenitor cells revert to stem cells upon crypt damage.

Authors:  Johan H van Es; Toshiro Sato; Marc van de Wetering; Anna Lyubimova; Annie Ng Yee Nee; Alex Gregorieff; Nobuo Sasaki; Laura Zeinstra; Maaike van den Born; Jeroen Korving; Anton C M Martens; Nick Barker; Alexander van Oudenaarden; Hans Clevers
Journal:  Nat Cell Biol       Date:  2012-09-23       Impact factor: 28.824

6.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Authors:  Matilde Todaro; Mileidys Perez Alea; Anna B Di Stefano; Patrizia Cammareri; Louis Vermeulen; Flora Iovino; Claudio Tripodo; Antonio Russo; Gaspare Gulotta; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

7.  YY1 is indispensable for Lgr5+ intestinal stem cell renewal.

Authors:  Ansu O Perekatt; Michael J Valdez; Melanie Davila; A Hoffman; Edward M Bonder; Nan Gao; Michael P Verzi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

8.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

9.  BMP restricts stemness of intestinal Lgr5+ stem cells by directly suppressing their signature genes.

Authors:  Zhen Qi; Yehua Li; Bing Zhao; Chi Xu; Yuan Liu; Haonan Li; Bingjie Zhang; Xinquan Wang; Xiao Yang; Wei Xie; Baojie Li; Jing-Dong Jackie Han; Ye-Guang Chen
Journal:  Nat Commun       Date:  2017-01-06       Impact factor: 14.919

10.  E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.

Authors:  Jean-Leon Chong; Pamela L Wenzel; M Teresa Sáenz-Robles; Vivek Nair; Antoney Ferrey; John P Hagan; Yorman M Gomez; Nidhi Sharma; Hui-Zi Chen; Madhu Ouseph; Shu-Huei Wang; Prashant Trikha; Brian Culp; Louise Mezache; Douglas J Winton; Owen J Sansom; Danian Chen; Rod Bremner; Paul G Cantalupo; Michael L Robinson; James M Pipas; Gustavo Leone
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

View more
  18 in total

Review 1.  Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Authors:  Linlin Fan; Xudong Yang; Minying Zheng; Xiaohui Yang; Yidi Ning; Ming Gao; Shiwu Zhang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

2.  A reinforcing HNF4-SMAD4 feed-forward module stabilizes enterocyte identity.

Authors:  Lei Chen; Natalie H Toke; Shirley Luo; Roshan P Vasoya; Robert L Fullem; Aditya Parthasarathy; Ansu O Perekatt; Michael P Verzi
Journal:  Nat Genet       Date:  2019-04-15       Impact factor: 41.307

Review 3.  Mouse models of colorectal cancer: Past, present and future perspectives.

Authors:  Florian Bürtin; Christina S Mullins; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

4.  Three-dimensional interactions between enhancers and promoters during intestinal differentiation depend upon HNF4.

Authors:  Lei Chen; Weihuan Cao; Rohit Aita; Dennis Aldea; Juan Flores; Nan Gao; Edward M Bonder; Christopher E Ellison; Michael P Verzi
Journal:  Cell Rep       Date:  2021-01-26       Impact factor: 9.423

5.  Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies.

Authors:  Zaoqu Liu; Yaxin Guo; Xiuxiu Yang; Chen Chen; Dandan Fan; Xiaoke Wu; Chaohua Si; Yanxin Xu; Bo Shao; Zhuang Chen; Qin Dang; Wenming Cui; Xinwei Han; Zhenyu Ji; Zhenqiang Sun
Journal:  Front Cell Dev Biol       Date:  2022-01-10

6.  Lineage Reversion Drives WNT Independence in Intestinal Cancer.

Authors:  Teng Han; Sukanya Goswami; Yang Hu; Fanying Tang; Maria Paz Zafra; Charles Murphy; Zhen Cao; John T Poirier; Ekta Khurana; Olivier Elemento; Jaclyn F Hechtman; Karuna Ganesh; Rona Yaeger; Lukas E Dow
Journal:  Cancer Discov       Date:  2020-06-16       Impact factor: 38.272

Review 7.  Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.

Authors:  Lia Walcher; Ann-Kathrin Kistenmacher; Huizhen Suo; Reni Kitte; Sarah Dluczek; Alexander Strauß; André-René Blaudszun; Tetyana Yevsa; Stephan Fricke; Uta Kossatz-Boehlert
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

8.  SMAD4 activates Wnt signaling pathway to inhibit granulosa cell apoptosis.

Authors:  Xing Du; Qiqi Li; Liu Yang; Lu Liu; Qiuyu Cao; Qifa Li
Journal:  Cell Death Dis       Date:  2020-05-15       Impact factor: 8.469

9.  Tgfβ signaling is critical for maintenance of the tendon cell fate.

Authors:  Guak-Kim Tan; Brian A Pryce; Anna Stabio; John V Brigande; ChaoJie Wang; Zheng Xia; Sara F Tufa; Douglas R Keene; Ronen Schweitzer
Journal:  Elife       Date:  2020-01-21       Impact factor: 8.140

Review 10.  Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.

Authors:  Yoshiro Itatani; Kenji Kawada; Yoshiharu Sakai
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.